SCHEMBL12026378

CSCCC(NC(=O)[C@H](C)NC(=O)C(CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)C(Cc1ccccc1)NC(C)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)N[C@H](C(=O)NC(CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C

nearest known ligand 0.69

Predicted protein targets (top 5)

	gene	UniProt	supporting neighbours	confidence
▸	IL23R	Q5VWK5	18/20	0.69

▸	RXFP1	Q9HBX9	1/20	0.67

▸	GLP1R	P43220	1/20	0.61

▸	GCGR	P47871	1/20	0.61

▸	GIPR	P48546	1/20	0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL12026377	1.00	IL23R (0.69)	IL23RRXFP1GLP1RGCGRGIPR
SCHEMBL12026383	0.98	RXFP1 (0.69)	IL23RRXFP1GLP1RGCGRGIPR
SCHEMBL12026389	0.98	RXFP1 (0.69)	IL23RRXFP1GLP1RGCGRGIPR
SCHEMBL12026376	0.95	IL23R (0.69)	IL23RRXFP1
SCHEMBL12026385	0.95	IL23R (0.69)	IL23RRXFP1
SCHEMBL12026379	0.94	IL23R (0.68)	IL23RRXFP1
SCHEMBL12026380	0.94	IL23R (0.68)	IL23RRXFP1
SCHEMBL16265093	0.90	RXFP1 (0.62)	IL23RRXFP1GLP1RGCGRGIPR
SCHEMBL16265092	0.90	RXFP1 (0.62)	IL23RRXFP1GLP1RGCGRGIPR
SCHEMBL31238593	0.88	KISS1R (0.65)	IL23RRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20110306565-A1	HYALURONIC ACID CONTAINING COMPOSITIONS FOR TREATMENT OF WOUNDS, SCARS, POST-SURGICAL ADHESION FORMATION	PERGAMUM AB (SE)	2011-12-15	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20110306565-A1	HYALURONIC ACID CONTAINING COMPOSITIONS FOR TREATMENT OF WOUNDS, SCARS, POST-SURGICAL ADHESION FORMATION	CD44, FN1, HDGF	IL23R 1367/4885RXFP1 322/4885GLP1R 2529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.